-
1دورية أكاديمية
المؤلفون: Alcázar-Navarrete, Bernardino, Jamart, Lucía, Sánchez-Covisa, Joaquín, Juárez, Mónica, Graefenhain, Ruth, Sicras-Mainar, Antoni
المصدر: CHEST; Nov2022, Vol. 162 Issue 5, p1017-1029, 13p
مصطلحات موضوعية: CHRONIC obstructive pulmonary disease, ELECTRONIC health records, TREATMENT effectiveness, RETROSPECTIVE studies, OBSTRUCTIVE lung disease diagnosis, ADRENERGIC beta agonists, DISEASE progression, ADRENOCORTICAL hormones, NEBULIZERS & vaporizers, BRONCHODILATOR agents, INHALATION administration, MUSCARINIC antagonists
مصطلحات جغرافية: SPAIN
-
2دورية أكاديمية
المؤلفون: Gershon, Andrea S., McGihon, Rachel E., Thiruchelvam, Deva, To, Teresa, Wu, Robert, Bell, Chaim M., Aaron, Shawn D., Canadian Respiratory Research Network
المصدر: CHEST; Mar2021, Vol. 159 Issue 3, p975-984, 10p
مصطلحات موضوعية: HOSPITAL admission & discharge, OBSTRUCTIVE lung diseases, COHORT analysis, MEDICATION reconciliation, DRUGS, OBSTRUCTIVE lung disease treatment, ADRENERGIC beta agonists, RESEARCH, FERRANS & Powers Quality of Life Index, ADRENOCORTICAL hormones, RESEARCH methodology, MEDICAL cooperation, EVALUATION research, BRONCHODILATOR agents, CONTINUUM of care, COMPARATIVE studies, CONTROLLED release preparations, QUALITY assurance, MENTAL health surveys, QUESTIONNAIRES, INHALATION administration, DISCHARGE planning, MUSCARINIC antagonists
-
3دورية أكاديمية
المؤلفون: Keller, Thomas, Spece, Laura J., Donovan, Lucas M., Udris, Edmunds, Coggeshall, Scott S., Griffith, Matthew, Bryant, Alexander D., Casaburi, Richard, Cooper, J. Allen, Criner, Gerard J., Diaz, Philip T., Fuhlbrigge, Anne L., Gay, Steven E., Kanner, Richard E., Martinez, Fernando J., Panos, Ralph J., Shade, David, Sternberg, Alice, Stibolt, Thomas, Stoller, James K.
المصدر: CHEST; Aug2020, Vol. 158 Issue 2, p529-538, 10p
مصطلحات موضوعية: OBSTRUCTIVE lung diseases, SECONDARY analysis, PROPORTIONAL hazards models, INHALERS, ADRENERGIC beta agonists, RESPIRATORY therapy equipment, ADRENOCORTICAL hormones, COMBINATION drug therapy, MEDICAL protocols, COMPARATIVE studies, OXYGEN therapy, QUALITY of life, RESEARCH funding, INHALATION administration, MUSCARINIC antagonists, DISEASE complications